Is Centrica PLC A White-Hot Growth Pick?

Royston Wild explains why Centrica PLC (LON: CNA) is a troublesome earnings pick.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am outlining why Centrica (LSE: CNA) could be considered a perilous stock for growth hunters.

Earnings volatility in the pipeline

Centrica has been one of the utilities sector’s poorest performers during the past year, the share price having surrendered more than a fifth over the past year due to rising questions over the firm’s future profitability.gasring

The firm saw earnings to stagnate in 2013 at 26.6p per share, and City analysts expect performance to worsen further in the current year as pressure at its downstream divisions bite. Indeed, the business is anticipated to experience a 20% dive, to 21.2p, although a 12% bounceback to 23.7p is pencilled in for 2015, helped by expectations of falling wholesale costs.

At current prices some would argue that these growth projections create decent value for money. Despite this year’s expected slide the energy giant trades on a P/E multiple of 15.1 times predicted earnings, just above the benchmark of 15 which illustrates attractive reasonable value for money. And 2015’s robust improvement drives this still lower, to 13.5.

Problems spread far and wide

But for many, the spectre of a worsening trading environment threatens to put the pressure on Centrica’s earnings potential in coming years. The company — like the rest of the ‘Big Six’ energy providers — is under close scrutiny from the Competition and Markets Authority (CMA) over profiteering and faces growing to be broken up.

Against this backcloth Centrica is undertaking a charm offensive to calm the rhetoric ahead of next year’s general election, and is holding off on initiating fresh price hikes at its British Gas subsidiary, in turn smacking revenue growth. Indeed, the company expects the average customer bill to be £90 lower this year from 2013 levels.

But the political problems facing Centrica are not just confined to these shores. Indeed, the effect of heavy sanctions on Russia due to its involvement in Ukraine threatens to scupper a deal the British firm made with Gazprom in 2012 to supply 2.4 billion cubic metres of gas from October. Although the Russian firm is yet to be hit by trade restrictions, the escalating crisis in Eastern Europe could force potential action and give Centrica a supply headache and weigh on the cost base.

Meanwhile the energy play also faces a number of other problems which could derail an earnings resurgence from next year, from the threat of a prolonged blackout at some ofEDF Energy’s British nuclear stations — in which Centrica hold a 20% interest — through to questions over the economic viability of renewable energy in the UK. I believe that Centrica is not a stock selection for the faint of heart.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »